Search Results - "Malek, Filip"

Commentary to the article The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies by Málek, Filip

Get full text

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) by Pudil, Radek, Danzig, Vilém, Veselý, Jiří, Málek, Filip, Táborský, Miloš, Elbl, Lubomír, Linhart, Aleš, Skalická, Hana

Get full text

Effect of Sodium−Glucose Co‐Transporter‐2 Inhibitor on Estimated Plasma Volume in a Patient With Heart Failure With Reduced Ejection Fraction and a Patient With Heart Failure With Preserved Ejection Fraction by Taťána, Andreasová, Filip, Málek

“…ABSTRACT Background The increased diuresis after sodium−glucose cotransporter 2 inhibitor (SGLT2i) was associated with a reduction of the estimated plasma…”
Get full text

A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial by Hasenfuß, Gerd, Prof, Hayward, Chris, Prof, Burkhoff, Dan, MD, Silvestry, Frank E, MD, McKenzie, Scott, MD, Gustafsson, Finn, MD, Malek, Filip, MD, Van der Heyden, Jan, MD, Lang, Irene, Prof, Petrie, Mark C, Prof, Cleland, John G F, Prof, Leon, Martin, Prof, Kaye, David M, Prof

“…Summary Background Heart failure with preserved ejection fraction (HFPEF) is a common, globally recognised, form of heart failure for which no treatment has…”
Get full text

Association of neuron-specific enolase values with outcomes in cardiac arrest survivors is dependent on the time of sample collection by Vondrakova, Dagmar, Kruger, Andreas, Janotka, Marek, Malek, Filip, Dudkova, Vlasta, Neuzil, Petr, Ostadal, Petr

“…Despite marked advances in intensive cardiology care, current options for outcome prediction in cardiac arrest survivors remain significantly limited. The aim…”
Get full text

Surgical ablation of the right greater splanchnic nerve for the treatment of heart failure with preserved ejection fraction: first‐in‐human clinical trial by Málek, Filip, Gajewski, Piotr, Zymliński, Robert, Janczak, Dariusz, Chabowski, Mariusz, Fudim, Marat, Martinca, Tomas, Neužil, Petr, Biegus, Jan, Mates, Martin, Krüger, Andreas, Skalský, Ivo, Bapna, Anisha, Engelman, Zoar J., Ponikowski, Piotr P.

“…Aims Inappropriate control of blood volume redistribution may be a mechanism responsible for exercise intolerance in heart failure with preserved ejection…”
Get full text

Commentary to the article "Optimizing Foundational Therapies in Patients With HFrEF. How Do We Translate These Findings Into Clinical Care?" by Málek, Filip, Táborský, Miloš

Get full text

Prognostic value of NT-proBNP added to clinical parameters to predict two-year prognosis of chronic heart failure patients with mid-range and reduced ejection fraction - A report from FAR NHL prospective registry by Spinar, Jindrich, Spinarova, Lenka, Malek, Filip, Ludka, Ondrej, Krejci, Jan, Ostadal, Petr, Vondrakova, Dagmar, Labr, Karel, Spinarova, Monika, Pavkova Goldbergova, Monika, Benesova, Klara, Jarkovsky, Jiri, Parenica, Jiri

“…According to guidelines, the prognosis of patients with chronic heart failure can be predicted by determining the levels of natriuretic peptides, the NYHA…”
Get full text

Novel Neuromodulation Approach to Improve Left Ventricular Contractility in Heart Failure: A First-in-Human Proof-of-Concept Study by Y. Reddy, Vivek, Petrů, Jan, Málek, Filip, Stylos, Lee, Goedeke, Steve, Neužil, Petr

“…Morbidity and mortality outcomes for patients admitted for acute decompensated heart failure are poor and have not significantly changed in decades. Current…”
Get full text

The effect of an inter-atrial communication in the treatment of the patients with heart failure with mildly reduced and preserved ejection fraction - current state of knowledge by Málek, Filip, Mates, Martin, Mráz, Tomáš, Reddy, Vivek, Krüger, Andreas, Neužil, Petr

Get full text

Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry by Spinar, Jindrich, Parenica, Jiri, Vitovec, Jiri, Widimsky, Petr, Linhart, Ales, Fedorco, Marian, Malek, Filip, Cihalik, Cestmír, Spinarová, Lenka, Miklik, Roman, Felsoci, Marian, Bambuch, Miroslav, Dusek, Ladislav, Jarkovsky, Jiri

“…The prognosis of patients hospitalized with acute heart failure (AHF) is poor and risk stratification may help clinicians guide care. The objectives of the…”
Get full text

2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure by McDonagh, Theresa A, Metra, Marco, Adamo, Marianna, Gardner, Roy S, Baumbach, Andreas, Böhm, Michael, Burri, Haran, Butler, Javed, Čelutkienė, Jelena, Chioncel, Ovidiu, Cleland, John G F, Crespo-Leiro, Maria Generosa, Farmakis, Dimitrios, Gilard, Martine, Heymans, Stephane, Hoes, Arno W, Jaarsma, Tiny, Jankowska, Ewa A, Lainscak, Mitja, Lam, Carolyn S P, Lyon, Alexander R, McMurray, John J V, Mebazaa, Alexandre, Mindham, Richard, Muneretto, Claudio, Francesco Piepoli, Massimo, Price, Susanna, Rosano, Giuseppe M C, Ruschitzka, Frank, Skibelund, Anne Kathrine

Get full text

Arterial hypertension and chronic heart failure by Málek, Filip

“…Abstract Arterial hypertension, alone or in combination with ischemic heart disease, precedes the development of heart failure. The Framingham study…”
Get full text

AHEAD score — Long-term risk classification in acute heart failure by Spinar, Jindrich, Jarkovsky, Jiri, Spinarova, Lenka, Mebazaa, Alexandre, Gayat, Etienne, Vitovec, Jiri, Linhart, Ales, Widimsky, Petr, Miklik, Roman, Zeman, Kamil, Belohlavek, Jan, Malek, Filip, Felsoci, Marian, Kettner, Jiri, Ostadal, Petr, Cihalik, Cestmir, Vaclavik, Jan, Taborsky, Miloš, Dusek, Ladislav, Littnerova, Simona, Parenica, Jiri

“…Abstract Background The role of co-morbidities in the prognosis of patients hospitalized for AHF was examined using the AHEAD ( A — atrial fibrillation, H —…”
Get full text

Prognostic value of high-sensitivity cardiac troponin I in heart failure patients with mid-range and reduced ejection fraction by Lokaj, Petr, Spinar, Jindrich, Spinarova, Lenka, Malek, Filip, Ludka, Ondrej, Krejci, Jan, Ostadal, Petr, Vondrakova, Dagmar, Labr, Karel, Spinarova, Monika, Pavkova Goldbergova, Monika, Miklikova, Marie, Helanova, Katerina, Parenicova, Ilona, Jakubo, Vladimir, Benesova, Klara, Miklik, Roman, Jarkovsky, Jiri, Ondrus, Tomas, Parenica, Jiri

“…Background The identification of high-risk heart failure (HF) patients makes it possible to intensify their treatment. Our aim was to determine the prognostic…”
Get full text

Reaching betablockers target dose in elderly patients with chronic heart failure by Málek, Filip

“…Abstract Despite overwhelming evidence of clinical efficacy, the use and dose of betablockers in elderly patients with chronic heart failure are often…”
Get full text

Long-Term Results of Hybrid Left Ventricular Reconstruction in the Treatment of Ischemic Cardiomyopathy by Naar, Jan, Skalský, Ivo, Krűger, Andreas, Málek, Filip, Van Bladel, Kevin, Annest, Lon S., Moučka, Petr, Mráz, Tomáš, Reddy, Vivek Y., Neužil, Petr

“…The evidence supporting surgical aneurysmectomy in ischemic heart failure is inconsistent. The aim of the study was to describe long-term effect of minimally…”
Get full text

Diabetes mellitus in stable chronic heart failure and the combination with humoral activation, their association, and prediction of 2‐year adverse outcomes. Data from the FAR NHL registry by Labr, Karel, Spinar, Jindrich, Parenica, Jiri, Spinarova, Lenka, Krejci, Jan, Malek, Filip, Ostadal, Petr, Ludka, Ondrej, Jarkovsky, Jiri, Benesova, Klara, Labrova, Ruzena, Spinarova, Monika

“…Background/Aim The study aims to describe the role of diabetes in patients with heart failure. Methods In all, 1052 chronic heart failure patients were…”
Get full text

Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial) by Hanff, Thomas C., Kaye, David M., Hayward, Christopher S., Post, Martijn C., Malek, Filip, Hasenfuβ, Gerd, Gustafsson, Finn, Burkhoff, Daniel, Shah, Sanjiv J., Litwin, Sheldon E., Kahwash, Rami, Hummel, Scott L., Borlaug, Barry A., Solomon, Scott D., Lam, Carolyn S.P., Komtebedde, Jan, Silvestry, Frank E.

“…In patients with heart failure and preserved or mildly reduced ejection fractions (EF ≥40%), implantation of an interatrial shunt device (IASD) resulted in…”
Get full text

Heart failure disease management program, its contribution to established pharmacotherapy and long-term prognosis in real clinical practice - retrospective data analysis by Lazarova, Marie, Lazar, Dusan, Malek, Filip, Vaclavik, Jan, Taborsky, Milos, Ignaszewski, Andrew

“…The prognosis of patients with heart failure (HF) is still generally unfavorable. HF with reduced ejection fraction (HFrEF) patients reach target medication…”
Get full text